Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-067659

EVP, Research & CSO sold 15,125 shares at an average $49.60 ($750,200)

  • EVP, Research & CSO acquired 15,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-30 Exercise or conversion : show line 1 in the form +15,125 $1.53 $23,141 122,825 D
2021-11-30 Sale : show line 2 in the form −1,375 $45.60 $62,700 121,450 D
2021-11-30 Sale : show line 3 in the form −13,750 $50.00 $687,500 107,700 D
Open-market sales · 15,125 sh · avg $49.60 · $750,200

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-30 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −15,125 230,505 D
Loading xslF345X03/doc4.xml…